| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |